Company / Total Assets
IDEAYA Biosciences, Inc. Total Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.1B
FY2025
5-year range
$381.3M / $1.1B
FY2021-FY2025
Trend
-1.3%
vs FY2024
Sector context
#76 of 214
Health Care
What the data says
At $1.1B, IDEAYA Biosciences, Inc.'s total assets ranks #76 of 214 in the Health Care sector. Improved from $649M to $1.1B over the past 2 years.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of +30.0%.
Improved from $649M to $1.1B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +41.9%
- 5-Year CAGR
- +30.0%
- 10-Year CAGR
- -
Sector benchmark
#76 of 214 in Health CareTop 36% of 214This company $1.1B Sector average $7.5B
▼
-85.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +30.0%, indicating consistent growth.
- In FY2025, total assets decreased 1.3% year-over-year.
- Ranks #76 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | -1.3% |
| FY2024 | $1.1B | +73.1% |
| FY2023 | $649.3M | +67.4% |
| FY2022 | $388.0M | +1.7% |
| FY2021 | $381.3M | +27.9% |
| FY2020 | $298.3M | +164.0% |
| FY2019 | $113.0M | +17.0% |
| FY2018 | $96.5M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026